Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-V:Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents

NCT01186120 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.

NCT NCT01186120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01186120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-V:Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents
Lead sponsor
Seung-Jung Park
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2013
Enrollment
500 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease